The onset of CS in tumor cells can typically be activated by aberrant activation of oncogenes or loss-of-function of tumor suppressor genes, and also by several stressors, including DNA damage, oxidative stress, and signaling through either MAPK or IGF [19]. Here, IGF1 is linked to neoplasm.